The company completed enrolling children aged 12 to 15 in the first study (NCT04368728) that aims to evaluate the safety, tolerability, immunogenicity, and efficacy of BNT162b2 vaccine.
The European Medicines Agency recommended granting a conditional marketing authorisation for COVID-19 Vaccine AstraZeneca to prevent COVID-19 disease in people from 18 years of age.
The second Apulian survey on the cryoconservation activities of human biological material coordinated by Agenzia Regionale Strategica per la Salute e il Sociale has been officially launched.
Fondazione Gianni Benzi provided its contribution to the public consultation on the revision of the European legislation on medicines for children and rare diseases launched by the European Commission.
The European Medicines Agency (EMA) has recommended the conditional marketing authorisation for COVID-19 Vaccine Moderna (mRNA-1273) that the European Commission granted. EMA’s human medicines committee has thoroughly assessed the data on the quality, safety...
European Medicines Agency has recommended granting a conditional marketing authorisation in the European Union for the vaccine Comirnaty, developed by BioNTech and Pfizer, to prevent COVID-19 in people from 16 years of age.
Calls for specialists and experts have just been published by the European Medicines Agency.
The Human Medicines Committee (CHMP) at EMA has started a rolling review of a new candidate vaccine for COVID-19, Ad26.COV2.S from Janssen-Cilag International N.V.
COVID-19 pandemic impacts the whole society in terms of socio-economic challenges as well as on the healthcare system worldwide. COVID-19 has been proven to be life-threatening to all patients especially those suffering from serious diseases.
The University of Pavia has launched the XVII second level post-graduate Master in Regulatory Sciences “G.Benzi”. The deadline for the submission of applications is January 26th, 2021.
Recent posts in News